Laxmi Organic Industries Ltd
Q3 FY25 Earnings Call Analysis
Chemicals & Petrochemicals
fundraise: Yescapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
๐ฐfundraise
Any current/future new fundraising through debt or equity?
- The company plans significant capex of around INR 1,100 crores, with INR 800 crores expected to be capitalized by FY '26 and the remainder in FY '27.
- To support this capex and operational needs, they anticipate term loans of approximately INR 400 to 500 crores by the second half (H2) of the financial year.
- The debt-to-equity ratio currently stands at a low 0.17, indicating a strong balance sheet and capacity to take on additional debt for growth.
- No mention of any equity fundraising or issuance in the provided transcript.
- Management emphasizes prudent capex spending and focused leveraging to drive shareholder and customer growth.
Summary: The company is raising debt (~INR 400-500 crores in term loans) to fund ongoing capex, with no current plans disclosed for equity fundraising.
๐๏ธcapex
Any current/future capex/capital investment/strategic investment?
- INR 1,100 crores total capex planned.
- Majority of capex focused on Dahej facility:
- Phase 1 mechanically complete and supplying customers.
- Phase 2 expected mechanical completion by Q4 FY '26.
- World-scale ethyl acetate plant at Lote:
- Mechanical completion expected by Q4 FY '26.
- Hitachi partnership project (Vayu):
- 60 metric tonnes capacity.
- INR 75 crores capex.
- Mechanical completion by Q2 FY '27.
- SF6 replacement project:
- Part of Vayu project capex.
- Supports eco-efficient gas EconiQ production.
- Diketene derivatives capacity to be doubled.
- Focus on productivity, commercial and execution excellence with capex to leverage growth.
The company plans no major fluorochem capex before FY '27, except SF6 replacement; further expansion decisions will be communicated later.
๐revenue
Future growth expectations in sales/revenue/volumes?
- Laxmi Organic is focused on growth despite a demanding global chemical industry backdrop with regional overcapacities.
- Expansion planned in Essentials and Specialty segments, with capacities near full utilization (90-95% in Essentials, fully utilized in diketene derivatives specialty).
- Fluorochem business expected to ramp up to 40-50% capacity utilization in FY '26, targeting INR 80 crores revenue with plans for expansion post-FY '27.
- New capex at Dahej (Phase 1 already supplying, Phase 2 mechanical completion by Q4 FY '26) and Lote facilities (fluorination ramp-up, ethyl acetate world-scale plant by Q4 FY '26).
- Partnership with Hitachi for SF6 replacement with 60 MT capacity and INR 75 crore capex, expected mechanical completion by Q2 next financial year.
- Cash flow from operations improving, with projects aimed at leveraging capital expenditures for shareholder and customer growth.
- Product alternatives and phased-out agrochemical intermediates mapped to recover specialty segment volumes and margins by FY '27.
๐margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Laxmi Organic anticipates steady growth driven by capacity expansions in Essentials and Specialty segments, including doubling diketene derivatives capacity.
- Fluorochem vertical is expected to grow post-FY27, with current revenues targeted around INR 80 crore in FY26 and plans to expand further thereafter.
- New capex at Dahej facility and the fluorination setup are key growth projects aimed at increasing productivity and volumes.
- The SF6 replacement project with Hitachi (60 MT capacity, INR 75 crore capex) is expected to be mechanically complete by Q2 FY27 and seen as a growth engine.
- Management emphasizes cost discipline, commercial excellence, and execution excellence to improve margins amid challenging market conditions.
- EBITDA margins in Specialty chemicals are anticipated to improve from current levels over the medium term, aided by new products replacing phased-out ones.
- Robust cash flow from operations and low debt-to-equity ratio provide financial strength to invest and support growth.
- Overall, the company remains โgeared to win and geared for growthโ with a focus on value creation for shareholders.
๐orderbook
Current/ Expected Orderbook/ Pending Orders?
- Laxmi Organic has a multiyear contract with a key customer for the Dahej Phase 1 facility, with the majority of capacity contractually lined up.
- Orders for the fluorination project and Hitachi collaboration are in ramp-up or execution phase, indicating ongoing demand.
- There is an order for the EconiQ grade product from Power Grid domestically, with major volumes targeted for export markets.
- Deferred deliveries from specialty chemicals in Q2 are expected to be fulfilled in the second half of the financial year (Q3 and Q4).
- No specific numerical order book values were disclosed due to competitive reasons, but management confirmed a healthy pipeline linked to growth projects and long-term agreements.
